Metraipolis › archive › dc_28db4063c827

Challenges and opportunities: CAR-T cell therapy in autoimmune diseases — Europe PMC PMID:42182589

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42182589
DOI
10.1016/j.cellin.2026.100327
License (as archived)
solo-consultazione
Archived
2026-11-03T06:16:15.453Z
SHA-256 of the archived text
5639251ed691d53fdfa03317402dc213aacc202beecf0d8b7b4e1f69a69c594a
Stable URL of this page
https://metraipolis.com/documento/dc_28db4063c827

How to cite

Challenges and opportunities: CAR-T cell therapy in autoimmune diseases — Europe PMC PMID:42182589 — Europe PMC (en), https://europepmc.org/article/MED/42182589 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_28db4063c827 (Metraipolis archive dc_28db4063c827, sha256 5639251ed691d53fdfa03317402dc213aacc202beecf0d8b7b4e1f69a69c594a)
BibTeX
@misc{dc28db4063c827,
  title = {Challenges and opportunities: CAR-T cell therapy in autoimmune diseases — Europe PMC PMID:42182589},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42182589},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_28db4063c827; sha256 5639251ed691d53fdfa03317402dc213aacc202beecf0d8b7b4e1f69a69c594a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42182589. Agents can read the archived copy with the MCP tool read_document.